Skip to content
Partaw Research
Menu

Advisory Board

The Advisory Board provides independent expert advice to Partaw Research on clinical governance, research design, and data governance. Its mandate, composition, and procedures are set out in the Charter below.

Inquire about appointmentRead the Charter

Adopted October 2026 · Version 1.0

1/ 3seats filledClinical governanceResearch designData governance

Composition

The Board comprises three seats, each held by one member appointed by invitation for a term of two years. Vacant seats are listed here before they are filled.

  1. Clinical governance

    The system by which a clinical service is held accountable for the quality and safety of its care.1

    • Which findings a radiologist must escalate to the referring clinic, and how fast
    • Which studies the service reads, and which it declines or refers on
    • How report quality is audited, including second reads and discrepancy review
    • Qualifications required of a signing radiologist
    • How errors and complaints are reviewed, and what changes as a result
    Vacant · Inquire

  2. Research design

    The scientific design of the Organization’s studies, from the question asked to the analysis that answers it.

    • Research questions and primary endpoints
    • Study protocols, sample size, and the reference standard results are judged against
    • Analysis plans, fixed before the data are examined
    • Ethics review and registration with each partner institution
    • Reporting against the recognized guideline for the study type
    MemberDr. Ghulam Qader QaderManagement Sciences for Health, Kabul

  3. Data governance

    The rules for how patient images and reports are collected, protected, and used in research.

    • The consent basis on which images enter the research corpus
    • De-identification standards, and how they are checked
    • Who may access the corpus, for what purpose, and under what agreement
    • Retention, security, and the deletion of data
    • Assurance that the corpus is never sold
    Vacant · Inquire

Terms of appointment

25

hours per year, not to exceed

Members may decline any individual request.

Article 5

4

meetings per year, by video conferenceArticle 5

2 wk

minimum period to review a documentArticle 5

2 yr

term of appointment, renewableArticle 4

None

remuneration; approved expenses reimbursedArticle 6

Principal provisions

A summary of the Charter’s main provisions. The articles below are the governing text.

  1. Advisory role

    The Board advises. It holds no authority to direct the Organization, to approve budgets or appointments, or to act on its behalf. Art. 2

  2. Conflicts of interest

    Members disclose relevant interests in writing on appointment and annually. Any paid engagement of a member by Partaw is published alongside the member’s name. Art. 7

  3. Data protection

    Members do not receive identifiable patient information. De-identified research data is accessed only under a written data-access agreement. Art. 8

  4. Authorship

    Authorship is determined by the criteria of the International Committee of Medical Journal Editors and recorded in each study protocol at the outset. Art. 9

  5. Public attribution

    A member’s name, affiliation, and seat are published only with written consent, and are withdrawn within seven days of a request. Art. 10

Charter

The governing text of the Advisory Board, in thirteen articles.

  1. 1

    Establishment

    1. 1.1This Charter establishes the Advisory Board (the “Board”) of Partaw Research (the “Organization”), the research and public-good arm of Partaw, and sets out its mandate, composition, and procedures.
    2. 1.2Partaw, the commercial entity that builds and operates the teleradiology platform on which the Organization’s research is conducted, is referred to in this Charter as the “Operator”.
  2. 2

    Mandate

    1. 2.1The Board provides independent expert advice to the Organization on clinical governance, research design, and data governance.
    2. 2.2The Board is advisory. It holds no authority to direct the Organization, to approve budgets or appointments, to enter into agreements, or to act on the Organization’s behalf. Until a governing board is constituted under Article 12, decisions of the Organization rest with its Founder.
  3. 3

    Composition

    1. 3.1The Board comprises three seats: clinical governance, research design, and data governance. Each seat is held by one member.
    2. 3.2Further seats may be created as the Organization’s programs require. A new seat is published on this page before it is filled.
  4. 4

    Appointment and term

    1. 4.1Members are appointed by invitation of the Founder and take office on written acceptance.
    2. 4.2A term of appointment is two years and may be renewed by mutual agreement.
    3. 4.3A member may resign at any time by written notice, effective on receipt. The Founder may end an appointment by written notice, stating the reason to the member.
  5. 5

    Meetings and duties

    1. 5.1The Board meets quarterly by video conference, for approximately one hour. Meetings are scheduled no less than two weeks in advance, with regard to members’ time zones.
    2. 5.2Between meetings, members may be asked to review documents within their seat’s area, including study protocols, governance drafts, and data-access requests, and are allowed no less than two weeks to respond.
    3. 5.3The total commitment is not expected to exceed approximately twenty-five hours per year. A member may decline any individual request.
  6. 6

    Remuneration and expenses

    1. 6.1Appointments are honorary and carry no remuneration.
    2. 6.2Reasonable expenses incurred on the Organization’s business and approved in writing in advance are reimbursed on receipt.
    3. 6.3Members are under no obligation to make or solicit financial contributions.
  7. 7

    Conflicts of interest

    1. 7.1Each member discloses in writing, on appointment and annually thereafter, any financial interest or role that bears on the work of the Board, including any engagement by the Operator, any interest in a competing teleradiology or imaging-AI enterprise, and any relationship with a prospective funder or partner. A conflict arising during a term is disclosed when it arises.
    2. 7.2A member with a conflict on a matter declares it and takes no part in the Board’s advice on that matter.
    3. 7.3Any paid engagement of a member by the Operator is published alongside the member’s name on this site.2
  8. 8

    Confidentiality and data protection

    1. 8.1Unpublished protocols, partner discussions, and preliminary results disclosed to members are held in confidence until published or released by the Organization.
    2. 8.2Members do not receive identifiable patient information. Access to de-identified research data is granted only under a written data-access agreement and for a stated purpose.
  9. 9

    Authorship and acknowledgment

    1. 9.1Membership of the Board does not of itself confer authorship.
    2. 9.2Authorship of any publication arising from the Organization’s research is determined by the criteria of the International Committee of Medical Journal Editors: substantial contribution to the conception or design of the work, or to the acquisition, analysis, or interpretation of its data; drafting the work or revising it critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work.
    3. 9.3Authorship is agreed at the outset of each study and recorded in its protocol. Contributors who do not meet all four criteria are acknowledged by name, with their consent.3
  10. 10

    Public attribution

    1. 10.1A member’s name, affiliation, and seat are published only with the member’s written consent, and are withdrawn within seven days of a request.
    2. 10.2Members serve in an individual capacity. Institutional affiliations are given for identification only and do not imply endorsement.
  11. 11

    Legal standing

    1. 11.1Members are not directors, officers, employees, or agents of the Organization or of the Operator. Membership confers no fiduciary duty, no obligation to contribute funds, and no power to bind either party.
  12. 12

    Incorporation

    1. 12.1The Organization is in the process of establishing formal nonprofit status and is seeking fiscal sponsorship in the interim.
    2. 12.2On incorporation or fiscal sponsorship, the governing board so constituted shall adopt this Charter or a successor instrument. Members are notified before any change takes effect.
    3. 12.3Membership of the Advisory Board confers no seat on the governing board. Members may be invited to serve on it by separate appointment.
  13. 13

    Amendment

    1. 13.1This Charter may be amended after members have been given no less than two weeks to comment on the proposed change. Each amendment is published on this page with its date of adoption.

Appointments

The clinical governance and data governance seats are vacant. Inquiries regarding appointment to the Board, or regarding the terms of this Charter, may be addressed to the Organization.

Contact the Organization

References

  1. 1Scally G, Donaldson LJ. Clinical governance and the drive for quality improvement in the new NHS in England. BMJ. 1998;317(7150):61–65. doi.org/10.1136/bmj.317.7150.61
  2. 2Internal Revenue Service. Form 1023: purpose of conflict of interest policy. www.irs.gov/charities-non-profits/form-1023-purpose-of-conflict-of-interest-policy
  3. 3International Committee of Medical Journal Editors. Defining the role of authors and contributors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html